Cricket ProteinGAINZNCT07159919
Insect vs Animal Protein for Building Muscle
A study testing protein supplement in people with Cricket Protein and Whey Protein, run by University of Surrey at 1 site in United Kingdom.
Trial summary
This research is being carried out to investigate the potential of insects (crickets) as a sustainable protein source for supporting human muscle tissue by comparing cricket protein to a commonly used animal protein (whey). Insects have been used as protein source for many years in East-Asian and African cultures. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cricket Protein, Whey Protein
- What is being tested?
- protein supplement
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 34 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 29 Nov 2025to Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adult males and females in general good health (aged 18+)
- BMI between 18.5 and 35 kg/m2
- Weight stable for 3 months (± 2 kg)
- Volunteers must be able and willing to give informed written consent
- Volunteers must be willing to provide blood and muscle tissue samples
- Volunteers must have been resistance training at least 3x per week for a minimum of 2 years
- Volunteers must be willing to follow a resistance training programme and consume a daily protein supplement for 12 weeks
- Not allergic to local anaesthetic
Who cannot join
- Injury or illness that prevents the adherence to 12 weeks resistance training and protein supplementation
- Those with metabolic conditions such as diabetes
- Those taking nutritional ergogenic aids (e.g. creatine, beta-alanine, sodium bicarbonate, dietary nitrate etc.)
- Those smoking, using nicotine products (e.g., e-cigarettes, patches) or not abstained from these activities for more than 6 months
- Pregnant or lactating (those who become pregnant during this study must notify the researchers immediately and the participant will be removed)
- Volunteers with a habitual caffeine intake >400 mg/day (more than 5 cups standard coffee)
Show all 12Show fewer
- Drug or alcohol abuse in the last 2 years
- Those who are taking performance enhancing drugs (PEDs) or have previously taken PEDs in the previous 10 years
- Those who do not refrain from alcohol, caffeine containing drinks (e.g., coffee, coca cola, tea, Red Bull) and strenuous exercise 12 hours before the phase 1 visit
- Those with food allergies
- Those following weight loss diets
- Those who are vegan, vegetarian or refrain from dairy/egg consumption
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom1 site, 1 recruiting
- Recruiting
University of Surrey, Stag Hill Campus
Guildford, Surrey, GU2 7XH
James AG Rutherford, MSc, +447540435440, j.rutherford@surrey.ac.uk
Ralph Manders, PhD, +441483 688668, r.manders@surrey.ac.uk
About this study
Official title: The Effect of Insect vs Animal Protein on Post-exercise Skeletal Muscle Anabolic Response and Chronic Adaption to Resistance Training
This research is being carried out to investigate the potential of insects (crickets) as a sustainable protein source for supporting human muscle tissue by comparing cricket protein to a commonly used animal protein (whey). Insects have been used as protein source for many years in East-Asian and African cultures. More recently the interest in this potential protein source has been growing in Western countries due to the negative environmental impact of producing animal foods and the increased awareness of animal welfare issues in the food chain. Insects are a more sustainable protein source, requiring less land, water and feed, and producing less carbon emissions (greenhouse gases) compared to farming livestock (e.g. cows, pigs, chickens etc.) However, up until now there is no clear evidence that insect-derived protein has the same nutritional properties as animal-derived protein. Recent data from our research group indicates that there appears to be no difference in the digestibility of an insect protein compared to a traditional animal protein amongst younger, middle-aged and older adults. The investigators now want to explore the potential of insect protein to increase muscle mass and strength.
Read the detailed description
Aims
- To investigate the impact of insect (cricket) compared to animal (whey) protein on skeletal muscle anabolism (building and repair of muscle tissue) following a bout of resistance exercise.
- To explore the change in muscle mass and strength following 12 weeks of resistance training whilst consuming cricket or whey protein daily.
Screening
Written informed consent will be taken prior to any procedures being performed. At the screening visit, participants will complete a health questionnaire and basic anthropometric measurements will also be taken (height and weight). The screening session will be conducted by a member of the research team at the University of Surrey physiology lab (Duke of Kent building). If all the inclusion criteria are met, the participant will be invited to join the study. Applicants who don't meet the inclusion criteria will be excluded from the study at this point. Screening data from excluded participants will not be stored, however a summary of how many participants were excluded and for what reasons will be kept for publication purposes. A favourable ethical opinion will be obtained from NHS ethics committee before starting this study. All participants will receive information about the procedures, risks, inconveniences, and benefits of participation from the investigator. Whilst the study does not aim to identify any health irregularities, participants will be informed prior to taking part that if any abnormal health parameter is identified then this will be highlighted to them and they may be advised to follow up with their GP.
Baseline testing
Following the screening visit, participants who have been enrolled onto the study will visit University of Surrey physiology lab to undergo baseline testing. This will begin with a body composition assessment using dual energy x-ray absorptiometry (DEXA), carried out by a trained member of staff who possesses an IR(ME)R certification for body composition scanning. A whole-body DEXA scan will be used to assess lean, fat and bone mass. Participants will then carry out a whole-body dynamic warm up before performing multiple strength tests to assess different indices of muscle strength. This will begin with a countermovement jump to assess explosive strength, followed by an isometric mid-thigh pull to assess maximum force production. This will be followed up by a 1 rep max (1RM) test on the bench press, squat and leg extension to measure upper and lower body maximal strength. The baseline testing will finish with a reps to failure test at 60% of 1RM on the bench press, squat and leg extension. Baseline exercise testing will be carried out by an exercise physiologist.
Phase 1 - Acute anabolic response
Participants will arrive at the lab in the morning after an overnight fast. A baseline venous blood sample (10ml) will be collected via a cannula. A baseline resting muscle biopsy will then be collected from the vastus lateralis of the non-exercise leg using a sterile Bio-Feather™ Semi-Automatic biopsy needle (14 Gauge x 100mm). The biopsy site will be cleaned with a sterile solution and a local anaesthetic (lidocaine) will be injected under the surface of the skin. To avoid any potential confounding effects caused by repeated sampling from the same location, a gap of at least 3cm between sequential biopsies will be maintained. Once the anaesthetic has taken effect, a cannula will be inserted into the muscle. A micro-biopsy needle will then be carefully inserted through the cannula and lowered to the required depth. The needle will be activated, and a small piece of muscle tissue (~20mg) will automatically be collected by the needle, the collection of the sample (from insertion to removal) will take approximately 3 - 5 seconds. Once, complete, the biopsy site will be dressed with a sterile dressing. In total ~60mg muscle tissue will be collected from each biopsy. Muscle tissue will be immediately dissected from any visible adipose or connective tissue and quickly frozen in liquid nitrogen and stored at -80oC until further analysis.
Participants will then perform 5 sets of single-leg resistance exercise using a leg extension machine. They will perform 1 set of 10 reps at 50% of their 1RM determined during the baseline testing visit. Then they will perform 3 sets of 8-10 reps at 80% of 1RM. The final set will also be performed at 80% 1RM but participants will be instructed to keep going until volitional failure if that does not occur after 8-10 reps. A 2-minute rest period will separate each set. This exercise will be overseen by an exercise physiologist.
Immediately following the exercise bout, participants will ingest a baked food product (dough balls) containing 30g of cricket protein (Bugvita, UK) or whey protein (Myprotein, UK). They will be encouraged to consume the food product within a 5-minute period. After ingestion, further blood samples (10ml) will be collected every 20 minutes for the first 60 minutes and then every 30 minutes from 60 - 240 minutes. All participants, regardless of which protein they consume, will also be asked to complete a short taste perception questionnaire to tell us their opinion of how the food product tasted. A further muscle biopsy will be taken from both the resting and exercise leg at 240 minutes after ingestion. In total, 10 blood samples (100ml) and 3 muscle biopsies (~180mg) will be collected during the test visit.
Following the final muscle biopsy, the cannula will be removed, all biopsy dressings will be inspected and then participants will leave the lab. Blood samples will be centrifuged at 1000 x g for 10 minutes at 4oC to separate the plasma, which will then be extracted into aliquots for storage in a -80oC freezer prior to analysis. Muscle tissue samples will be stored in accordance with the Human Tissue Act 2004 in a designated HTA licensed lab at the University of Surrey.
Phase 2 - Chronic training and supplementation
Following phase 1, participants will be randomly assigned to consume 30g of protein from cricket or whey daily for 12 weeks. This will be in the form of the food product used in phase 1. During this time participants will follow a progressive resistance training programme designed to increase muscle mass and strength. Participants will train 3-4 times per week and follow a high protein diet (2g/kg/day) which will be supplemented by the daily intake of cricket or whey protein. The training programme will be designed an exercise physiologist and participants will be instructed not to engage in any other structured exercise during this period.
Participants will be given daily calorie targets based on their estimated total daily energy expenditure to ensure that they are consuming enough energy to grow muscle. A small calorie surplus of 10% will be the daily energy intake target for each participant, given that increasing muscle mass is best achieved in a positive net energy balance. Nutritional targets will be devised by a sports nutritionist.
Participants will be asked to provide a weekly training log via a smartphone app at the beginning, the middle and the end of the 12-week intervention period to ensure that they were performing the required training volume. They will also be asked to provide a 3-day food diary via smartphone app at the beginning, middle and end of the 12-week intervention period to ensure that they were adhering to the nutritional targets set by the research team. The research team will check-in with participants at regular intervals throughout the intervention period either in-person or online to assess progress and tackle any difficulties that participants might be experiencing with the training or dietary targets.
Following the completion of the 12 weeks, participants will return to the University of Surrey physiology lab to repeat the same body composition assessment (DEXA) and strength tests which they performed during the baseline testing visit.
- Conditions
- Cricket Protein, Whey Protein
- Being tested
- protein supplement
- Keywords
- Insect protein, Sustainable nutrition, Alternative protein, Muscle anabolism, Body composition, Strength, Muscle mass, Resistance training
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
protein supplementDietary supplement
Also called Cricket protein
Cricket protein incorporated into a whole-food source (dough balls) to be consumed once after an acute bout of resistance exercise and then consumed daily for 12 weeks alongside regular resistance training.
protein supplementDietary supplement
Also called Whey protein
Whey protein incorporated into a whole-food source (dough balls) to be consumed once after an acute bout of resistance exercise and then consumed daily for 12 weeks alongside regular resistance training.
| Study group | Role | What they receive |
|---|---|---|
| Cricket protein | Experimental | Group consuming cricket protein Receives: Dietary Supplement: protein supplement |
| Whey protein | Active comparator | Group consuming whey protein Receives: Dietary Supplement: protein supplement |
What is being measured
The primary outcome is the main question the study is designed to answer.
Anabolic signalling
Changes in mTORC1 signalling in skeletal muscle from baseline to post-prandial following cricket or whey protein ingestion after exercise
Measured: From baseline measurement to 6 hours later
Muscle mass
Changes in lean mass following 12 weeks of daily consumption of cricket or whey protein in conjunction with regular resistance training
Measured: From baseline measures at enrolment to the end of the training and supplementation period at 12 weeks
Muscle strength
Changes in muscular strength following 12 weeks of daily consumption of cricket or whey protein in conjunction with regular resistance training
Measured: From baseline measures at enrolment to the end of the training and supplementation period at 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Sep 2025
- Study start29 Nov 2025
- Primary completionJan 2027 (estimated)
- Study completionJan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cricket ProteinStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 34 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Surrey
- Sponsor type
- University, hospital or other
- Collaborators
- Aberystwyth University
- Responsible party
- Sponsor
- Investigators
- Ralph Manders, PhD, Principal investigator, University of Surrey
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07159919
- Sponsor's protocol ID
- GAINZ
- Acronym
- GAINZ
- Status last verified
- Aug 2025
- First submitted
- 26 Aug 2025
- Last updated
- 29 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: IPD will only be shared amongst the researchers involved in this study.
Publications
Aragon, A., Schoenfeld, B. Magnitude and Composition of the Energy Surplus for Maximizing Muscle Hypertrophy: Implications for Bodybuilding and Physique Athletes. Strength and Conditioning Journal 42(5):p 79-86, October 2020.
Study at a glance
From the registry record, last updated by the sponsor on 29 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Insect vs Animal Protein on Post-exercise Skeletal Muscle Anabolic Response and Chronic Adaption to Resistance Training
- ClinicalTrials.gov ID
- NCT07159919
- Acronym / sponsor ID
- GAINZ / GAINZ
- Conditions
- Cricket Protein, Whey Protein
- Keywords
- Insect protein, Sustainable nutrition, Alternative protein, Muscle anabolism, Body composition, Strength, Muscle mass, Resistance training
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 34 participants (estimated)
- Lead sponsor
- University of SurreyUniversity, hospital or other
- Collaborators
- Aberystwyth University
- Study start
- 29 Nov 2025 (actual)
- Primary completion
- Jan 2027 (estimated)
- Study completion
- Jan 2027 (estimated)
- First posted
- 8 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research is being carried out to investigate the potential of insects (crickets) as a sustainable protein source for supporting human muscle tissue by comparing cricket protein to a commonly used animal protein (whey). Insects have been used as protein source for many years in East-Asian and African cultures. More recently the interest in this potential protein source has been growing in Western countries due to the negative environmental impact of producing animal foods and the increased awareness of animal welfare issues in the food chain. Insects are a more sustainable protein source, requiring less land, water and feed, and producing less carbon emissions (greenhouse gases) compared to farming livestock (e.g. cows, pigs, chickens etc.) However, up until now there is no clear evidence that insect-derived protein has the same nutritional properties as animal-derived protein. Recent data from our research group indicates that there appears to be no difference in the digestibility of an insect protein compared to a traditional animal protein amongst younger, middle-aged and older adults. The investigators now want to explore the potential of insect protein to increase muscle mass and strength.
Detailed description
Aims
- To investigate the impact of insect (cricket) compared to animal (whey) protein on skeletal muscle anabolism (building and repair of muscle tissue) following a bout of resistance exercise.
- To explore the change in muscle mass and strength following 12 weeks of resistance training whilst consuming cricket or whey protein daily.
Screening
Written informed consent will be taken prior to any procedures being performed. At the screening visit, participants will complete a health questionnaire and basic anthropometric measurements will also be taken (height and weight). The screening session will be conducted by a member of the research team at the University of Surrey physiology lab (Duke of Kent building). If all the inclusion criteria are met, the participant will be invited to join the study. Applicants who don't meet the inclusion criteria will be excluded from the study at this point. Screening data from excluded participants will not be stored, however a summary of how many participants were excluded and for what reasons will be kept for publication purposes. A favourable ethical opinion will be obtained from NHS ethics committee before starting this study. All participants will receive information about the procedures, risks, inconveniences, and benefits of participation from the investigator. Whilst the study does not aim to identify any health irregularities, participants will be informed prior to taking part that if any abnormal health parameter is identified then this will be highlighted to them and they may be advised to follow up with their GP.
Baseline testing
Following the screening visit, participants who have been enrolled onto the study will visit University of Surrey physiology lab to undergo baseline testing. This will begin with a body composition assessment using dual energy x-ray absorptiometry (DEXA), carried out by a trained member of staff who possesses an IR(ME)R certification for body composition scanning. A whole-body DEXA scan will be used to assess lean, fat and bone mass. Participants will then carry out a whole-body dynamic warm up before performing multiple strength tests to assess different indices of muscle strength. This will begin with a countermovement jump to assess explosive strength, followed by an isometric mid-thigh pull to assess maximum force production. This will be followed up by a 1 rep max (1RM) test on the bench press, squat and leg extension to measure upper and lower body maximal strength. The baseline testing will finish with a reps to failure test at 60% of 1RM on the bench press, squat and leg extension. Baseline exercise testing will be carried out by an exercise physiologist.
Phase 1 - Acute anabolic response
Participants will arrive at the lab in the morning after an overnight fast. A baseline venous blood sample (10ml) will be collected via a cannula. A baseline resting muscle biopsy will then be collected from the vastus lateralis of the non-exercise leg using a sterile Bio-Feather™ Semi-Automatic biopsy needle (14 Gauge x 100mm). The biopsy site will be cleaned with a sterile solution and a local anaesthetic (lidocaine) will be injected under the surface of the skin. To avoid any potential confounding effects caused by repeated sampling from the same location, a gap of at least 3cm between sequential biopsies will be maintained. Once the anaesthetic has taken effect, a cannula will be inserted into the muscle. A micro-biopsy needle will then be carefully inserted through the cannula and lowered to the required depth. The needle will be activated, and a small piece of muscle tissue (~20mg) will automatically be collected by the needle, the collection of the sample (from insertion to removal) will take approximately 3 - 5 seconds. Once, complete, the biopsy site will be dressed with a sterile dressing. In total ~60mg muscle tissue will be collected from each biopsy. Muscle tissue will be immediately dissected from any visible adipose or connective tissue and quickly frozen in liquid nitrogen and stored at -80oC until further analysis.
Participants will then perform 5 sets of single-leg resistance exercise using a leg extension machine. They will perform 1 set of 10 reps at 50% of their 1RM determined during the baseline testing visit. Then they will perform 3 sets of 8-10 reps at 80% of 1RM. The final set will also be performed at 80% 1RM but participants will be instructed to keep going until volitional failure if that does not occur after 8-10 reps. A 2-minute rest period will separate each set. This exercise will be overseen by an exercise physiologist.
Immediately following the exercise bout, participants will ingest a baked food product (dough balls) containing 30g of cricket protein (Bugvita, UK) or whey protein (Myprotein, UK). They will be encouraged to consume the food product within a 5-minute period. After ingestion, further blood samples (10ml) will be collected every 20 minutes for the first 60 minutes and then every 30 minutes from 60 - 240 minutes. All participants, regardless of which protein they consume, will also be asked to complete a short taste perception questionnaire to tell us their opinion of how the food product tasted. A further muscle biopsy will be taken from both the resting and exercise leg at 240 minutes after ingestion. In total, 10 blood samples (100ml) and 3 muscle biopsies (~180mg) will be collected during the test visit.
Following the final muscle biopsy, the cannula will be removed, all biopsy dressings will be inspected and then participants will leave the lab. Blood samples will be centrifuged at 1000 x g for 10 minutes at 4oC to separate the plasma, which will then be extracted into aliquots for storage in a -80oC freezer prior to analysis. Muscle tissue samples will be stored in accordance with the Human Tissue Act 2004 in a designated HTA licensed lab at the University of Surrey.
Phase 2 - Chronic training and supplementation
Following phase 1, participants will be randomly assigned to consume 30g of protein from cricket or whey daily for 12 weeks. This will be in the form of the food product used in phase 1. During this time participants will follow a progressive resistance training programme designed to increase muscle mass and strength. Participants will train 3-4 times per week and follow a high protein diet (2g/kg/day) which will be supplemented by the daily intake of cricket or whey protein. The training programme will be designed an exercise physiologist and participants will be instructed not to engage in any other structured exercise during this period.
Participants will be given daily calorie targets based on their estimated total daily energy expenditure to ensure that they are consuming enough energy to grow muscle. A small calorie surplus of 10% will be the daily energy intake target for each participant, given that increasing muscle mass is best achieved in a positive net energy balance. Nutritional targets will be devised by a sports nutritionist.
Participants will be asked to provide a weekly training log via a smartphone app at the beginning, the middle and the end of the 12-week intervention period to ensure that they were performing the required training volume. They will also be asked to provide a 3-day food diary via smartphone app at the beginning, middle and end of the 12-week intervention period to ensure that they were adhering to the nutritional targets set by the research team. The research team will check-in with participants at regular intervals throughout the intervention period either in-person or online to assess progress and tackle any difficulties that participants might be experiencing with the training or dietary targets.
Following the completion of the 12 weeks, participants will return to the University of Surrey physiology lab to repeat the same body composition assessment (DEXA) and strength tests which they performed during the baseline testing visit.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Cricket protein | Experimental | Dietary Supplement: protein supplementGroup consuming cricket protein |
| Whey protein | Active comparator | Dietary Supplement: protein supplementGroup consuming whey protein |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Adult males and females in general good health (aged 18+)
- BMI between 18.5 and 35 kg/m2
- Weight stable for 3 months (± 2 kg)
- Volunteers must be able and willing to give informed written consent
- Volunteers must be willing to provide blood and muscle tissue samples
Key exclusion criteria (12 listed)
- Injury or illness that prevents the adherence to 12 weeks resistance training and protein supplementation
- Those with metabolic conditions such as diabetes
- Those taking nutritional ergogenic aids (e.g. creatine, beta-alanine, sodium bicarbonate, dietary nitrate etc.)
- Those smoking, using nicotine products (e.g., e-cigarettes, patches) or not abstained from these activities for more than 6 months
- Pregnant or lactating (those who become pregnant during this study must notify the researchers immediately and the participant will be removed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| protein supplementAlso: Cricket proteinCricket protein incorporated into a whole-food source (dough balls) to be consumed once after an acute bout of resistance exercise and then consumed daily for 12 weeks alongside regular resistance training. | Dietary supplement | Cricket protein |
| protein supplementAlso: Whey proteinWhey protein incorporated into a whole-food source (dough balls) to be consumed once after an acute bout of resistance exercise and then consumed daily for 12 weeks alongside regular resistance training. | Dietary supplement | Whey protein |
Primary outcome
Anabolic signalling
Time frame: From baseline measurement to 6 hours later
Changes in mTORC1 signalling in skeletal muscle from baseline to post-prandial following cricket or whey protein ingestion after exercise
Muscle mass
Time frame: From baseline measures at enrolment to the end of the training and supplementation period at 12 weeks
Changes in lean mass following 12 weeks of daily consumption of cricket or whey protein in conjunction with regular resistance training
Muscle strength
Time frame: From baseline measures at enrolment to the end of the training and supplementation period at 12 weeks
Changes in muscular strength following 12 weeks of daily consumption of cricket or whey protein in conjunction with regular resistance training
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2026.
- BackgroundAragon, A., Schoenfeld, B. Magnitude and Composition of the Energy Surplus for Maximizing Muscle Hypertrophy: Implications for Bodybuilding and Physique Athletes. Strength and Conditioning Journal 42(5):p 79-86, October 2020.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No. IPD will only be shared amongst the researchers involved in this study.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ralph Manders, PhD principal investigator
University of Surrey
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing protein supplement in people with Cricket Protein and Whey Protein, run by University of Surrey at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact James AG Rutherford, MSc (+447540435440, j.rutherford@surrey.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Anabolic signalling (time frame: From baseline measurement to 6 hours later). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07159919, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.